1Chyatte D, Bruno G, Desai S, et al. Inflammation and intracranial aneurysms. Neurosurgery, 1999,45 (5):1137-1147.
2Barnes MJ. Collagens in atherosclerosis. Collagen Rel Res, 1985,5(1):65-97.
3Peters DG, Kassam A, St Jean PL, et al. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke, 1999,30 (12):2612-2616.
4McGirt MJ, Lynch JR, Blessing R, et al. Serum von willebrand factor, matrix metalloproteinase-9 and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurismal subarachnoid hemorrhage. Neurosurgery, 2002, 51(5):1128-1134.
5Ferrara N, Houck KA,Jakeman LB, et al. The vascular endothelial growth factor family of polypeptides. J Cell Biochem, 1991,47(3):211-218.
6Skirgaudas M, Awad IA, Kim J, et al. Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery, 1996,39(3):537-547.
7Riedel F,Gotte K,Schwalb J,et al. Expression of 92-k Da type Ⅳ collagenase correlates with angiogenic markers and poor survival in head and neck aquamous cell caricinoma. Int J Oncol, 2000,17(6) : 1099-1105.
8Riedel F,Gotte K,Bergler W,et al. Inverse correlation of a poptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol Rep, 2001,8 (3):471-476.
9Kim I,Kim HG, Moon SO, et al. Angiopoictin Ⅰ induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretin. Cire Res, 2000,86 (9):952-959.
10Fang J, Shing Y,Wiedersehain D, et al. Matric metalloproteinase-2 is required for the switch to the angiogenie phenotype in tumor mode. Proc Natl Acad Sci USA,2000,97(8):3884-3889.
2Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage[J]. Stroke, 1994, 25(7) :1342 - 1347.
3Yamaguchi M, Jadhav V, Obenaus A, et al. Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury[ J]. Neurosurgery, 2007, 61 ( 5 ) : 1067 - 1076.
4Liu X, Han Q, Sun R, et al. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis[J]. Brain Res, 2008, 1207( ) :237 -243.
5Prunell GF, Mathiesen T, Diemer NH, et al. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models[ J]. Neurosurgery, 2003, 52( 1 ) :165 - 176.
6Wang X, Jung J, Asahi M, et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury [ J ]. J Neurosci, 2000, 20 ( 18 ) : 7037 - 7042.
7Pfohman M, Criddle LM. Epidemiology of intracranial aneurysm and subarachnoid hemorrhage [ J]. J Neurosci Nurs, 2001, 33 (1):39 -41.
8Kusaka G, Ishikawa M, Nanda A, et al. Signaling pathways for early brain injury after subarachnoid hemorrhage [ J ]. J Cereb Blood Flow Metab, 2004, 24(8) : 916 -925.
9Cahill J, Calvert JW, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage [ J ]. J Cereb Blood Flow Metab, 2006, 26( 11 ) : 1341 - 1353.
10Humann GF, Okata Y, Fitridge R, et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion [J]. Stroke, 1995, 26(11) :2121 -2129.
